• Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2020 year
    06 day
    New start point of Winhealth in medical cosmetology

     ——Firming-effect ultrasonic therapeutic instrument of Merz launched at Boao Super Hospital 

    Relying its policy advantage granted by the State Council for the import of licensed medical devices, Boao Super Hospital, which is located in Boao Lecheng International Medical Tourism Pilot Zone, has recently introduced Ulthery®, a micro-point focused ultrasound therapeutic instrument manufactured by Ulthera (U.S.) under Merz Pharma GmbH (Germany). As a strategic partner of Merz in Mainland China, Hongkong Winhealth Pharma Group Co., Ltd was fully responsible for assisting the licensed import of Ultherapy® into the pilot zone in Hainan, and for expert coordination, registration application, entry into hospitals and patient operations, and has achieved good results. 

     维健医美领域新起点 助力德国麦施Merz提拉功效超声治疗仪落地博鳌超级医院

    This is the only FDA-certified non-invasive beauty treatment device in the world with the skin firming effect and visualization patent imaging technology, according to sources. On January 5, 2020, one of the first patients in Mainland China received the Ultherapy® treatment at Medical Beauty Center headed by Professor Zhang Xuejun of Boao Super Hospital.


    维健医美领域新起点 助力德国麦施Merz提拉功效超声治疗仪落地博鳌超级医院

    Ultherapy® is an innovative medical technology that can firm the eyebrow and loose submental (under the chin) and cervical skin, and improve intimate crumpling and wrinkles in the chest, said Mr. Li Bin, Greater China Region general manager of Merz Pharma GmbH (Germany). Ultherapy® has been certified and marketed in more than 70 countries and regions in Europe, North and South America, Australia and Asia with more than 1.5 million cases of treatment. In his speech, Mr. Li Bin mentioned in particular that he thanked Hongkong Winhealth Pharma Group Co., Ltd for its important role as a strategic partner in facilitating import registration approval for the project.


    维健医美领域新起点 助力德国麦施Merz提拉功效超声治疗仪落地博鳌超级医院 维健医美领域新起点 助力德国麦施Merz提拉功效超声治疗仪落地博鳌超级医院

    Professor Zhang Xuejun from Dermatology Center of Boao Super Hospital said that Ultherapy® has a real firming effect. At present, the so-called US Version ultrasound knife widely circulated in the medical beauty market is actually Ultherapy®, which forms a unique thermal freezing point accurately and clearly by focusing ultrasonic waves on specific soft tissue layers of the epidermis, starts collagen denaturation and remodeling of new collagen without damaging the skin surface, and achieves the effect of initial firming to continuous firming. It helps sub-healthy patients with loose skin to achieve the effect of 'visible firming'.


    Liu Zhefeng, deputy director of Boao Lecheng International Medical Tourism Pilot Zone, said that Boao Lecheng was established to allow more domestic patients to use the latest international medical technologies and products without going abroad or leaving the island. It is hoped that the successful introduction of Ultherapy® into Dermatology Center of Boao Super Hospital will actively bring cutting-edge technologies and more innovative medical products to the field of medical health, provide more comprehensive services for more patients and people with sub-healthy skin, help them build a better life and realize the Beautiful China dream.

    The successful introduction of Ultherapy® marks a new starting point of Winhealth Pharma Group in the field of licensing and medical cosmetology, as well as another strong cooperation between Winhealth and the medical cosmetology giant Merz. In 2020, Winhealth Pharma Group will make full use of the open door policy of Lecheng Pilot Zone, and devote itself to introducing more high-quality and innovative medical device products from abroad into the pilot zone at the earliest time to meet the medical needs of Chinese patients.

    About Hongkong Winhealth Pharma Group Co., Ltd

    Winhealth Group is a one-stop professional service platform focusing on the whole process from drug registration application, product import, market access, commercialization implementation to life cycle management. As a new-type pharmaceutical enterprise promoting the development of China's pharmaceutical health industry, the Group is committed to introducing the world's leading health products and medical technologies into the Chinese market, providing medical staff with more excellent treatment methods and medical information dissemination channels, providing patients with more treatment and rehabilitation resources, and building itself into a leading provider of full-cycle, integrated and customized market access solutions and a Contract Development and Commercialization Organization (CDCO).

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.